Skip to main content
SpringerLink
Log in
Book cover

Helicobacter pylori pp 387–396Cite as

Amoxicillin

  • Chapter
  • First Online:

Abstract

Treatment of Helicobacter pylori (H. pylori) is warranted and normally done with combination of antibiotics (such as amoxicillin, clarithromycin, or others) and a proton pump inhibitor. However, the eradication rate of legacy triple therapy has been decreasing because of the increase in resistance to clarithromycin. Likewise, treatment failure due to amoxicillin, a primary antimicrobial agent for H. pylori eradication, resistance has been noted since 20 years ago. Increasing levels of resistance to amoxicillin contribute to treatment failures, and higher levels of resistance are believed to be due to multiple genetic mutations. However, the exact mechanism of amoxicillin resistance and its contribution to eradication failure has not been fully elucidated.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet. 2009;374:1449–61.

    Article  CAS  PubMed  Google Scholar 

  2. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136:487–90.

    Article  CAS  PubMed  Google Scholar 

  4. Lam SK, Talley NJ. Report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol. 1998;13:1–12.

    Article  CAS  PubMed  Google Scholar 

  5. Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology. 2007;133:985–1001.

    Article  CAS  PubMed  Google Scholar 

  6. Boyanova L, Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther. 2010;8:59–70.

    Article  CAS  PubMed  Google Scholar 

  7. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut. 2004;53:1374–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lind T, Mégraud F, Unge P, Bayerdörffer E, O’Morain C, Spiller R, et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology. 1999;116:248–53.

    Article  CAS  PubMed  Google Scholar 

  9. De Francesco V, Margiotta M, Zullo A, Hassan C, Troiani L, Burattini O, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med. 2006;144:94–100.

    Article  PubMed  Google Scholar 

  10. Agudo S, Alarcón T, Cibrelus L, Urruzuno P, Martinez MJ, López-Brea M. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Rev Esp Quimioter. 2009;22:88–92.

    CAS  PubMed  Google Scholar 

  11. Liu Z, Shen J, Zhang L, Shen L, Li Q, Zhang B, et al. Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. BMC Microbiol. 2008;8:81.

    Article  PubMed  PubMed Central  Google Scholar 

  12. De Francesco V, Zullo A, Ierardi E, Giorgio F, Perna F, Hassan C, et al. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrob Chemother. 2010;65:327–32.

    Article  PubMed  Google Scholar 

  13. Kim JM, Kim JS, Kim N, Kim YJ, Kim IY, Chee YJ, et al. Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients. J Microbiol Biotechnol. 2008;18:1584–9.

    CAS  PubMed  Google Scholar 

  14. Kim N, Kim JM, Kim CH, Park YS, Lee DH, Kim JS, et al. Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea. J Clin Gastroenterol. 2006;40:683–7.

    Article  CAS  PubMed  Google Scholar 

  15. Binh TT, Suzuki R, Kwon DH, Yamaoka Y. Complete genome sequence of a metronidazole-resistant Helicobacter pylori strain. Genome Announc. 2015;3:e00051–15.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Binh TT, Suzuki R, Trang TT, Kwon DH, Yamaoka Y. Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother. 2015;59:2343–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gisbert JP, Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Aliment Pharmacol Ther. 2011;34:1255–68.

    Article  CAS  PubMed  Google Scholar 

  18. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol. 2002;31:128–39.

    Article  PubMed  Google Scholar 

  19. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence consensus report. Gut. 2012;61:646–64.

    Article  CAS  PubMed  Google Scholar 

  20. DeLoney CR, Schiller NL. Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob Agents Chemother. 1999;43:2702–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis. 2010;19:409–14.

    PubMed  Google Scholar 

  22. Gerrits MM, Godoy AP, Kuipers EJ, Ribeiro ML, Stoof J, Mendonca S, et al. Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori. Helicobacter. 2006;11:181–7.

    Article  CAS  PubMed  Google Scholar 

  23. Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, Kuipers EJ, Kusters JG, Vandenbroucke-Grauls CM. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother. 1999;43:511–5.

    Article  CAS  PubMed  Google Scholar 

  24. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1996;40:477–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. van Zwet AA, de Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur J Clin Microbiol Infect Dis. 1996;15:861–4.

    Article  PubMed  Google Scholar 

  26. Vasquez A, Valdez Y, Gilman RH, McDonald JJ, Westblom TU, Berg D, et al. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University. J Clin Microbiol. 1996;34:1232–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Wu W, Yang Y, Sun G. Recent insights into antibiotic resistance in Helicobacter pylori eradication. Gastroenterol Res Pract. 2012;2012:723183.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Dore MP, Graham DY, Sepulveda AR. Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori. Helicobacter. 1999;4:154–61.

    Article  CAS  PubMed  Google Scholar 

  29. Meyer JM, Silliman NP, Wang W, Siepman NY, Sugg JE, Morris D, et al. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993–1999. Ann Intern Med. 2002;136:13–24.

    Article  PubMed  Google Scholar 

  30. Glupczynski Y, Mégraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 2001;20:820–3.

    Article  CAS  PubMed  Google Scholar 

  31. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34–42.

    Article  CAS  PubMed  Google Scholar 

  32. Ndip RN, Malange Takang AE, Ojongokpoko JE, Luma HN, Malongue A, Akoachere JF, et al. Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram. Trop Med Int Health. 2008;13:848–54.

    Article  PubMed  Google Scholar 

  33. Seck A, Mbengue M, Gassama-Sow A, Diouf L, Ka MM, Boye CS. Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal. J Infect Dev Ctries. 2009;3:137–40.

    Article  PubMed  Google Scholar 

  34. Kobayashi I, Murakami K, Kato M, Kato S, Azuma T, Takahashi S, et al. Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol. 2007;45:4006–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Hung KH, Sheu BS, Chang WL, Wu HM, Liu CC, Wu JJ. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter. 2009;14:61–5.

    Article  CAS  PubMed  Google Scholar 

  36. Hu CT, Wu CC, Lin CY, Cheng CC, Su SC, Tseng YH, et al. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. J Gastroenterol Hepatol. 2007;22:720–3.

    CAS  PubMed  Google Scholar 

  37. Watanabe K, Tanaka A, Imase K, Tokunaga K, Sugano H, Kai A, et al. Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003. Helicobacter. 2005;10:4–11.

    Article  CAS  PubMed  Google Scholar 

  38. Hwang TJ, Kim N, Kim HB, Lee BH, Nam RH, Park JH, et al. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol. 2010;44:536–43.

    CAS  PubMed  Google Scholar 

  39. Wilke MS, Lovering AL, Strynadka NC. Beta-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol. 2005;8:525–33.

    Article  CAS  PubMed  Google Scholar 

  40. Goffin C, Ghuysen JM. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev. 1998;62:1079–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Born P, Breukink E, Vollmer W. In vitro synthesis of cross-linked murein and its attachment to sacculi by PBP1A from Escherichia coli. J Biol Chem. 2006;281:26985–93.

    Article  CAS  PubMed  Google Scholar 

  42. Handsfield HH, Clark H, Wallace JF, Holmes KK, Turck M. Amoxicillin, a new penicillin antibiotic. Antimicrob Agents Chemother. 1973;3:262–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Faghri J, Poursina F, Moghim S, Zarkesh Esfahani H, Nasr Esfahani B, Fazeli H, et al. Morphological and bactericidal effects of different antibiotics on Helicobacter pylori. Jundishapur J Microbiol. 2014;7:e8704.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Berry V, Jennings K, Woodnutt G. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob Agents Chemother. 1995;39:1859–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Costa K, Bacher G, Allmaier G, Dominguez-Bello MG, Engstrand L, Falk P, et al. The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J Bacteriol. 1999;181:3710–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Blumberg PM, Strominger JL. Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes. Bacteriol Rev. 1974;38:291–335.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Ghuysen JM. Penicillin-binding proteins. Wall peptidoglycan assembly and resistance to penicillin: facts, doubts and hopes. Int J Antimicrob Agents. 1997;8:45–60.

    Article  CAS  PubMed  Google Scholar 

  48. Harris AG, Hazell SL, Netting AG. Use of digoxigenin-labelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori. J Antimicrob Chemother. 2000;45:591–8.

    Article  CAS  PubMed  Google Scholar 

  49. Krishnamurthy P, Parlow MH, Schneider J, Burroughs S, Wickland C, Vakil NB, et al. Identification of a novel penicillin-binding protein from Helicobacter pylori. J Bacteriol. 1999;181:5107–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Ikeda F, Yokota Y, Mine Y, Tatsuta M. Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins. Antimicrob Agents Chemother. 1990;34:2426–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Dore MP, Osato MS, Realdi G, Mura I, Graham DY, Sepulveda AR. Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother. 1999;43:47–54.

    Article  CAS  PubMed  Google Scholar 

  52. van Zwet AA, Vandenbroucke-Grauls CM, Thijs JC, van der Wouden EJ, Gerrits MM, Kusters JG. Stable amoxicillin resistance in Helicobacter pylori. Lancet. 1998;352:1595.

    Article  PubMed  Google Scholar 

  53. Kwon DH, Dore MP, Kim JJ, Kato M, Lee M, Wu JY, et al. High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003;47:2169–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Co EM, Schiller NL. Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother. 2006;50:4174–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Gerrits MM, Schuijffel D, van Zwet AA, Kuipers EJ, Vandenbroucke-Grauls CM, Kusters JG. Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother. 2002;46:2229–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis. 2006;6:699–709.

    Article  CAS  PubMed  Google Scholar 

  57. Paul R, Postius S, Melchers K, Schäfer KP. Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin. Antimicrob Agents Chemother. 2001;45:962–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Rimbara E, Noguchi N, Kawai T, Sasatsu M. Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori. Microbiol Immunol. 2007;51:939–44.

    Article  CAS  PubMed  Google Scholar 

  59. Kim JM. Antibiotic resistance of Helicobacter pylori isolated from Korean patients. Korean J Gastroenterol. 2006;47:337–49.

    PubMed  Google Scholar 

  60. Qureshi NN, Morikis D, Schiller NL. Contribution of specific amino acid changes in penicillin binding protein 1 to amoxicillin resistance in clinical Helicobacter pylori isolates. Antimicrob Agents Chemother. 2011;55:101–9.

    Article  CAS  PubMed  Google Scholar 

  61. Okamoto T, Yoshiyama H, Nakazawa T, Park ID, Chang MW, Yanai H, et al. A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J Antimicrob Chemother. 2002;50:849–56.

    Article  CAS  PubMed  Google Scholar 

  62. Tseng YS, Wu DC, Chang CY, Kuo CH, Yang YC, Jan CM, et al. Amoxicillin resistance with beta-lactamase production in Helicobacter pylori. Eur J Clin Invest. 2009;39:807–12.

    Article  CAS  PubMed  Google Scholar 

  63. Matteo MJ, Granados G, Olmos M, Wonaga A, Catalano M. Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates. J Antimicrob Chemother. 2008;61:474–7.

    Article  CAS  PubMed  Google Scholar 

  64. DeLoney CR, Schiller NL. Characterization of an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother. 2000;44:3368–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Qureshi NN, Gallaher B, Schiller NL. Evolution of amoxicillin resistance of Helicobacter pylori in vitro: characterization of resistance mechanisms. Microb Drug Resist. 2014;20:509–16.

    Article  CAS  PubMed  Google Scholar 

  66. Kim BJ, Kim JG. Substitutions in penicillin-binding protein 1 in amoxicillin-resistant Helicobacter pylori strains isolated from Korean patients. Gut Liver. 2013;7:655–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastric Cancer Center, Kyungpook National University Medical Center, 807 Hoguk-ro, Buk-gu, Daegu, 41404, South Korea

    Yong Hwan Kwon MD

Authors
  1. Yong Hwan Kwon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yong Hwan Kwon MD .

Editor information

Editors and Affiliations

  1. Seoul National University, Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea (Republic of)

    Nayoung Kim

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Kwon, Y.H. (2016). Amoxicillin. In: Kim, N. (eds) Helicobacter pylori. Springer, Singapore. https://doi.org/10.1007/978-981-287-706-2_37

Download citation

  • DOI: https://doi.org/10.1007/978-981-287-706-2_37

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-287-705-5

  • Online ISBN: 978-981-287-706-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation